Drug Type Small molecule drug |
Synonyms Grepafloxacin, Grepafloxacin hydrochloride (JAN/USAN), Grepax + [6] |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (06 Nov 1997), |
Regulation- |
Molecular FormulaC19H23ClFN3O3 |
InChIKeyIEPMBYOIQGCVHO-UHFFFAOYSA-N |
CAS Registry161967-81-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02178 | Grepafloxacin Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bronchitis, Chronic | US | 06 Nov 1997 | |
Community Acquired Pneumonia | US | 06 Nov 1997 | |
Gonorrhea | US | 06 Nov 1997 | |
Uterine Cervicitis | US | 06 Nov 1997 |